• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/3

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

3 Cards in this Set

  • Front
  • Back

HYPERTENSION - systolic blood pressure greater than or equal to 140 mmHg or diastolic blood pressure greater than or equal to 90 mmHg or taking hypertensive medication




American Cardiac society and American heart association - Grades



Elevated arteriolar pressure


Normal - 120/80


Elevated; systolic btwn 120-129 diastolic Less than 80


Stage 1- systole 130-139 or diastole 80-89


Stage 2 systole at least 140, diastole at least 90




Hypertensive Crisis/ malignant hypertension - systolic over 180, diastole over 120,. Patient needing prompt change in medication






Clinical features



Asymptomatic


Headache


Blurred vision


Dizziness





Epidemiology



Age standardized prevalence - 24.5%


Only 15.7% were aware


Factors associated - older age, higher BMI, harmful alcohol use, being male





Classification



Essential/ primary hypertension


Unknown causes but genetics and environmental influences



Secondary


Cardiovascular ( coarctation of aorta, polyarteritis nodosa, high intravascular volume, high CO, rigidity of aorta)



Endocrine


Adrenal hyperfunction eg Cushing, hyperaldosteronism



Exogenous hormones eg glucocorticoids, estrogen, MAO inhibitor, tyramine foods eg chocolate




Physiology


Eg increase in growth hormone


Hyperthyroidism


Pregnancy



Renal- acute glomerulonephritis, chronic glomerulonephritis, polycystic kidney, renal artery stenosis, renal vasculitis, reninomas


Neurogenic


Acute stress eg surgery


Psychogenic


High ICP


Sleep



Pathogenesis of essential hypertension



Genetic factors



As determined by monozygotic and dizygotic twins


Hypertension within families


Polygenic and heterogenic traits


Several mutation or gene polymorphism



Eg aldosterone synthetase - 11 beta hydroxylase


17- alpha hydroxylase


Lead to high secretion of aldosterone, salt water retention, increase plasma volume



Angiotensin II and I receptor altered to increase



Na resorption mutations eg liddle syndrome - salt sensitive hypertension




Environmental - Chinese American






Pathogenicity mechanism



1.Vasoconstriction or arteriosclerosis/ hypertrophy



a. Neurogenic factors increase BP in stress


b. Increase in vasoconstrictor- renin angiotensin aldosterone system, catecholamines, endothelin



c. Arteriosclerosis



2. Sodium retention


Angiotensin- angiotensin I - angiotensin II- Adlosterone- increased mineral corticosteroids- increase Na resorption


Gilelman syndrome- NaCl co transporter


Liddle syndrome- beta and alpha ENAC


Pseudohyperaldosteronism - alpha and beta subunits of ENAC



Result


Vasoconstriction- peripheral resistance


Increased ECF/ intravascular fluid volume


Increased Co



Hypertension


Pathological change





Hyaline arteriosclerosis - in old age, diabetic


Hyaline thickened arterioles wall, luminal narrowing


Chronic BP create turbulence with endothelial damage, leakage of plasma cells across endothelium and hyaline deposit



Hypertrophic arteriosclerosis


Concentric laminated thickening of arterioles wall, onion skin appearance, luminal narrowing



Necrotizing arteriolitis


Focal fibrinoid necrosis in hypertrophic vessels







Complications of hypertension



Hypertensive heart disease


Atherosclerosis


Cerebrovascular accident


Retinopathy


Nephropathy


IUFD/IUFGR






Clinical presentation



Asymptomatic - silent killer


Palpitation


Headache


Nausea


Vomiting


Difficulty in breathing


Poor vision


Loss of pregnancy

HYPERTENSIVE HEART disease



Heart muscle disease complicating systemic arteriole hypertension leading to concentric hypertrophy of Left ventricle and Ischemia in absence of ather condition that can cause LV hypertrophy





History of systemic arteriole hypertension






Pathogenesis



Myocyte hypertrophy in response to increased workload due to increased peripheral resistance



Hypertrophic myocardum reduce LV compliance, impairing diastolic filling



Individual myocyte hypertrophy increase the distance for oxygen and nutrient diffusion from adjacent capillaries



Associated coronary artery atherosclerosis accompany hypertension further cause Ischemia







Morphology



Concentric Left ventricle hypertrophy Great than 20mm



Weight 500+ g


Narrow lumen



Microscopy - increased transverse diameter of myocardum, irregular nuclei enlargement, variation in myocyte size , fibrosis, irregular myocardiocytes

Complications of HYPERTENSIVE HEART disease



Heart failure


Pulmonary oedema


Arrythmias - atrial fibrillation


CVAs complicating atrial fibrillation









HYPERTENSIVE retinopathy



Malignant hypertension leads to acute vasospasm and narrowing


Onion skin appearance


Grade I II III



Flame hemorrhages; dot and blot , cotton wool appearance, hard waxy exudate








HYPERTENSIVE nephropathy



Long standing essential hypertension


Endothelial damage


Arteritis


Increased permeability - fibrin


Intravascular thrombosis


Platelets growth factor lead to Intimal smooth muscle hyperplasia



Ischemia to kidney



Angiotensin renin mechanism triggered


Vicious cycle



Gross


Fleas bitten appearance, due to hemorrhage, larger kidney initially, shrunken kidney later with uniform granular surface and capsular adhesion




Microscopy


Fibrinoid necrosis, inflammatory cells infiltrate, hyperplastic arteriolitis ( onion skin) , necrotizing glomerulonephritis - thrombosed capillaries , inflammatory cells infiltrate, infarct



Uncontrollable 60% die in 3. Months


90%. Die in one year




Accelerated


Thrombotic microangiopathy eg HUS, TTP


Intimal edema, RBC fragmentations, onion skin fibrosis

Effects due to placental changes




Abruptio placenta - IUFD, Intrauterine hypoxia


Placental insufficiency -. Small for gestational age, IUFGR, IUFD




Placental changes in hypertension



Infarct


Increased syncytial knots


Hypovascularity of villi


Cytotrophoblastic proliferation


Thickening of trophoblastic basement membrane


Obliterative enlarged endothelial cells in fetal capillaries


Atherosis of spiral arteries in placental bed




Effects


Placental insufficiency


Fetal growth retardation



Due to occlusion of uteroplacental vasculature and placental Ischemia